Literature DB >> 34508711

DNA-binding activities of compounds acting as enzyme inhibitors, ion channel blockers and receptor binders.

Ruslans Muhamedejevs1, Lada Živković2, Maija Dzintare3, Nikolajs Sjakste4.   

Abstract

The DNA-binding activities of compounds used as remedies can display DNA-protection, but also damaging effects in biological systems. The current review compiles literature data on DNA-binding activities of drugs widely used as remedies with different therapeutic indications. The compounds are classified according their mechanism of action: enzyme inhibitors, ion channel inhibitors, inhibitors of viral RNA replication and HIV protease and receptor agonists. DNA binding was reported for such widely used drugs as paracetamol, aspirin, metformin, statins and many others. The capability of the drug to bind DNA is sometimes coupled to genotoxic effects, but in some cases - to genome protection. Data on atoms and chemical groups involved in the drug-DNA interactions are also presented. In many cases the same atoms are involved in both interactions of the compounds with proteins and DNA.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Enzyme inhibitors; Inhibitors of viral RNA replication and HIV protease; Interactions with DNA; Ion channel inhibitors; Receptor agonists

Mesh:

Substances:

Year:  2021        PMID: 34508711     DOI: 10.1016/j.cbi.2021.109638

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  2 in total

1.  Comments on "DNA-binding activities of compounds acting as enzyme inhibitors, ion channel blockers and receptor binders."

Authors:  Hartmut Jaeschke
Journal:  Chem Biol Interact       Date:  2021-11-26       Impact factor: 5.192

2.  Drug-Targeted Genomes: Mutability of Ion Channels and GPCRs.

Authors:  Regan Raines; Ian McKnight; Hunter White; Kaitlyn Legg; Chan Lee; Wei Li; Peter H U Lee; Joon W Shim
Journal:  Biomedicines       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.